Gene analysis (protein phosphatase 2 regulatory subunit bbeta) for abnormal alleles
Medicare pricing data for 22 providers across 7 states
This is a specialized procedure with relatively few Medicare claims. Pricing data may be less reliable due to smaller sample sizes. Note: These costs reflect the Medicare physician/supplier component. Hospital facility fees are billed separately and can be 2-5x the physician fee.
💡 What You Should Know
Gene analysis (protein phosphatase 2 regulatory subunit bbeta) for abnormal alleles (HCPCS code 81343) is a medical procedure billed to Medicare. The average Medicare-allowed cost is $134.26, but hospitals typically charge $158.72 — a 1.2x markup. Prices vary significantly by state and provider.
🏷️ Typical Out-of-Pocket Cost
Medicare patients typically pay about 20% of the allowed amount as coinsurance. Based on the average allowed cost of $134.26, your out-of-pocket cost would be approximately $26.85. Actual costs depend on your specific plan, deductible, and whether you've met your annual out-of-pocket maximum.
What Hospitals Charge vs. What Medicare Pays
Hospitals charge 1.2x more than what Medicare allows for this procedure. Medicare actually pays $134.26 on average.
Cost by State
Medicare-allowed amounts vary significantly by state
| State | Allowed Cost | Hospital Charge | Providers | Services | vs. National |
|---|---|---|---|---|---|
| Louisiana | $134 | $161 | 1 | 47 | 0.0% |
| New Jersey | $134 | $166 | 4 | 3,025 | 0.0% |
| Oklahoma | $134 | $190 | 1 | 58 | 0.0% |
| Pennsylvania | $134 | $137 | 1 | 1,103 | 0.0% |
| Texas | $134 | $146 | 4 | 1,189 | 0.0% |
| Colorado | $134 | $602 | 1 | 14 | 0.0% |
| Florida | $134 | $174 | 10 | 503 | -0.0% |
⚠️ Important: These costs reflect the Medicare physician/supplier component. Hospital facility fees may be billed separately. Total out-of-pocket costs may be higher.
💊 Need post-procedure medications? Check costs on OpenPrescriber